Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Applied Therapeutics Inc (NQ: APLT )

9.625 +0.355 (+3.83%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,801,133
Open 9.350
Bid (Size) 9.280 (50)
Ask (Size) 9.900 (1)
Prev. Close 9.270
Today's Range 8.950 - 9.640
52wk Range 1.790 - 10.62
Shares Outstanding 114,846,271
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Applied Therapeutics Reports Third Quarter 2024 Financial Results
From Applied Therapeutics
Via GlobeNewswire
Applied Therapeutics to Present at the 2024 UBS Global Healthcare Conference
From Applied Therapeutics
Via GlobeNewswire

Performance

YTD
+164.42%
+164.42%
1 Month
+14.18%
+14.18%
3 Month
+62.04%
+62.04%
6 Month
+131.93%
+131.93%
1 Year
+423.10%
+423.10%

More News

Read More
Steelcase Reports Weak Sales, Joins American Healthcare REIT And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Via Benzinga
Dow Jumps Over 100 Points; Fed Cuts Interest Rates By 0.5%
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Why Applied Therapeutics Stock Is Skyrocketing Today
Via The Motley Fool
Crude Oil Moves Lower; PowerFleet Shares Spike Higher
Via Benzinga
Exposures Fossil Fuels
Russell 2000 Outpaces S&P 500 As Small Caps Anticipate Fed's Interest Rate Move
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Applied Therapeutics Stock Soars As FDA Scraps Panel Meeting For Its Inherited Metabolic Disorder Drug
Via Benzinga
Exposures Product Safety
Applied Therapeutics, PowerFleet, VF Corp, Victoria's Secret And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Applied Therapeutics Provides Regulatory Update on Govorestat for the Treatment of Classic Galactosemia
From Applied Therapeutics
Via GlobeNewswire
Why Champions Oncology Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Applied Therapeutics to Participate in Upcoming Investor Conferences
From Applied Therapeutics
Via GlobeNewswire
Applied Therapeutics Reports Second Quarter 2024 Financial Results
From Applied Therapeutics
Via GlobeNewswire
Rare Disease-Focused Applied Therapeutics' Lead Candidate Govorestat Has Blockbuster Potential, Analyst Sees 140% Stock Upside
Via Benzinga
CrossFirst Bankshares Posts Q2 Earnings, Joins Owens & Minor, Reddit And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
Applied Therapeutics Added to Russell 3000® Index
From Applied Therapeutics
Via GlobeNewswire
Top 4 Health Care Stocks That May Keep You Up At Night This Month
Via Benzinga
APLT Stock Earnings: Applied Therapeutics Meets EPS, Misses Revenue for Q1 2024
Via InvestorPlace
Applied Therapeutics Reports First Quarter 2024 Financial Results
From Applied Therapeutics
Via GlobeNewswire
Applied Therapeutics to Present at the 2024 RBC Capital Markets Global Healthcare Conference
From Applied Therapeutics
Via GlobeNewswire
Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer
From Applied Therapeutics
Via GlobeNewswire
Applied Therapeutics to Present Results from Phase 3 ARISE-HF Study in Diabetic Cardiomyopathy at ACC 2024
From Applied Therapeutics
Via GlobeNewswire
FDA Presses Delay Button For Applied Therapeutics' First Potential Marketed Drug For Rare Disease
Via Benzinga
Exposures Product Safety
Why Doma Holdings Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.